1
|
Greenfield JA, Scherer R, Alba D, De Arrigunaga S, Alvarez O, Palioura S, Nanji A, Bayyat GA, da Costa DR, Herskowitz W, Antonietti M, Jammal A, Al-Khersan H, Wu W, Shousha MA, O'Brien R, Galor A, Medeiros FA, Karp CL. Detection of Ocular Surface Squamous Neoplasia Using Artificial Intelligence With Anterior Segment Optical Coherence Tomography. Am J Ophthalmol 2025; 273:182-191. [PMID: 39983942 PMCID: PMC11985264 DOI: 10.1016/j.ajo.2025.02.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2024] [Revised: 02/12/2025] [Accepted: 02/13/2025] [Indexed: 02/23/2025]
Abstract
PURPOSE To develop and validate a deep learning (DL) model to differentiate ocular surface squamous neoplasia (OSSN) from pterygium and pinguecula using high-resolution anterior segment optical coherence tomography (AS-OCT). DESIGN Retrospective Diagnostic Accuracy Study. METHODS Setting: Single-center. STUDY POPULATION All eyes with a clinical or biopsy-proven diagnosis of OSSN, pterygium, or pinguecula that received AS-OCT imaging. PROCEDURES Imaging data was extracted from Optovue AS-OCT (Fremont, CA) and patients' clinical or biopsy-proven diagnoses were collected from electronic medical records. A DL classification model was developed using two methodologies: (1) a masked autoencoder was trained with unlabeled data from 105,859 AS-OCT images of 5746 eyes and (2) a Vision Transformer supervised model coupled to the autoencoder used labeled data for fine-tuning a binary classifier (OSSN vs non-OSSN lesions). A sample of 2022 AS-OCT images from 523 eyes (427 patients) were classified by expert graders into "OSSN or suspicious for OSSN" and "pterygium or pinguecula." The algorithm's diagnostic performance was evaluated in a separate test sample using 566 scans (62 eyes, 48 patients) with biopsy-proven OSSN and compared with expert clinicians who were masked to the diagnosis. Analysis was conducted at the scan-level for both the DL model and expert clinicians, who were not provided with clinical images or supporting clinical data. MAIN OUTCOME Diagnostic performance of expert clinicians and the DL model in identifying OSSN on AS-OCT scans. RESULTS The DL model had an accuracy of 90.3% (95% confidence intervals [CI]: 87.5%-92.6%), with sensitivity of 86.4% (95% CI: 81.4%-90.4%) and specificity of 93.2% (95% CI: 89.9%-95.7%) compared to the biopsy-proven diagnosis. Expert graders had a lower sensitivity 69.8% (95% CI: 63.6%-75.5%) and slightly higher specificity 98.5% (95% CI: 96.4%-99.5%) than the DL model. The area under the receiver operating characteristic curve for the DL model was 0.945 (95% CI: 0.918-0.972) and significantly greater than expert graders (area under the receiver operating characteristic curve = 0.688, P < .001). CONCLUSIONS A DL model applied to AS-OCT scans demonstrated high accuracy, sensitivity, and specificity in differentiating OSSN from pterygium and pinguecula. Interestingly, the model had comparable diagnostic performance to expert clinicians in this study and shows promise for enhancing clinical decision-making. Further research is warranted to explore the integration of this artificial intelligence-driven approach in routine screening and diagnostic protocols for OSSN.
Collapse
Affiliation(s)
- Jason A Greenfield
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Rafael Scherer
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Diego Alba
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Sofia De Arrigunaga
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Osmel Alvarez
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Sotiria Palioura
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Afshan Nanji
- Oregon Health & Science University (A.N.), Portland, Oregon, USA
| | | | - Douglas Rodrigues da Costa
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - William Herskowitz
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Michael Antonietti
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Alessandro Jammal
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Hasenin Al-Khersan
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Winfred Wu
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Mohamed Abou Shousha
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Robert O'Brien
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Anat Galor
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA; Department of Ophthalmology (A.G.), Miami Veterans Administration Medical Center, Miami, Florida, USA
| | - Felipe A Medeiros
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Carol L Karp
- From the Bascom Palmer Eye Institute (J.A.G., R.S., D.A., S.D.A., O.A., S.P., D.R.C., W.H., M.A., A.J., H.A.K., W.W., M.A.S., R.O., A.G., F.A.M., C.L.K.), University of Miami Miller School of Medicine, Miami, Florida, USA.
| |
Collapse
|
2
|
Feng H, Chen J, Zhang Z, Lou Y, Zhang S, Yang W. A bibliometric analysis of artificial intelligence applications in macular edema: exploring research hotspots and Frontiers. Front Cell Dev Biol 2023; 11:1174936. [PMID: 37255600 PMCID: PMC10225517 DOI: 10.3389/fcell.2023.1174936] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Accepted: 05/02/2023] [Indexed: 06/01/2023] Open
Abstract
Background: Artificial intelligence (AI) is used in ophthalmological disease screening and diagnostics, medical image diagnostics, and predicting late-disease progression rates. We reviewed all AI publications associated with macular edema (ME) research Between 2011 and 2022 and performed modeling, quantitative, and qualitative investigations. Methods: On 1st February 2023, we screened the Web of Science Core Collection for AI applications related to ME, from which 297 studies were identified and analyzed (2011-2022). We collected information on: publications, institutions, country/region, keywords, journal name, references, and research hotspots. Literature clustering networks and Frontier knowledge bases were investigated using bibliometrix-BiblioShiny, VOSviewer, and CiteSpace bibliometric platforms. We used the R "bibliometrix" package to synopsize our observations, enumerate keywords, visualize collaboration networks between countries/regions, and generate a topic trends plot. VOSviewer was used to examine cooperation between institutions and identify citation relationships between journals. We used CiteSpace to identify clustering keywords over the timeline and identify keywords with the strongest citation bursts. Results: In total, 47 countries published AI studies related to ME; the United States had the highest H-index, thus the greatest influence. China and the United States cooperated most closely between all countries. Also, 613 institutions generated publications - the Medical University of Vienna had the highest number of studies. This publication record and H-index meant the university was the most influential in the ME field. Reference clusters were also categorized into 10 headings: retinal Optical Coherence Tomography (OCT) fluid detection, convolutional network models, deep learning (DL)-based single-shot predictions, retinal vascular disease, diabetic retinopathy (DR), convolutional neural networks (CNNs), automated macular pathology diagnosis, dry age-related macular degeneration (DARMD), class weight, and advanced DL architecture systems. Frontier keywords were represented by diabetic macular edema (DME) (2021-2022). Conclusion: Our review of the AI-related ME literature was comprehensive, systematic, and objective, and identified future trends and current hotspots. With increased DL outputs, the ME research focus has gradually shifted from manual ME examinations to automatic ME detection and associated symptoms. In this review, we present a comprehensive and dynamic overview of AI in ME and identify future research areas.
Collapse
Affiliation(s)
- Haiwen Feng
- Department of Software Engineering, School of Software, Shenyang University of Technology, Shenyang, Liaoning, China
| | - Jiaqi Chen
- Department of Software Engineering, School of Software, Shenyang University of Technology, Shenyang, Liaoning, China
| | - Zhichang Zhang
- Department of Computer, School of Intelligent Medicine, China Medical University, Shenyang, Liaoning, China
| | - Yan Lou
- Department of Computer, School of Intelligent Medicine, China Medical University, Shenyang, Liaoning, China
| | - Shaochong Zhang
- Shenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China
| | - Weihua Yang
- Shenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China
| |
Collapse
|
3
|
Liu J, Li R, Han K, Yu X, Tang Y, Zhao H. Intravitreal injection of Conbercept combined with micropulse laser therapy enhances clinical efficacy in patients with diabetic macular edema. Am J Transl Res 2023; 15:531-538. [PMID: 36777842 PMCID: PMC9908468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Accepted: 12/23/2022] [Indexed: 02/14/2023]
Abstract
PURPOSE To analyze the clinical efficacy of intravitreal injection of Conbercept (IVC) combined with micropulse laser (MPL) therapy in the treatment of diabetic macular edema (DME). METHODS In this retrospective study, we selected 64 DME patients who visited the First People's Hospital of Yunnan Province between February 2019 and February 2021 for analysis. Based on different intervention methods, 31 cases treated with IVC were included as a control group (the Con group) and 33 cases with IVC + MPL combination therapy were in a research group (the Res group). Data on curative effects, injection frequency, pre- and post-treatment best corrected visual acuity (BCVA) and central macular thickness (CMT), visual field gray value, 30° visual field average light threshold sensitivity, and mean visual field defect (VFD) were collected for inter-group comparisons. Further, Cox multivariate regression analysis was performed to identify factors affecting the curative efficacy of DME patients. RESULTS Compared with the Con group, the Res group had a higher total response rate and a lower injection frequency. In addition, higher BCVA and lower CMT were determined in the Res after 6 months of treatment. Moreover, Res group exhibited statistically lower visual field gray value and mean VFD, as well as higher 30° visual field average light threshold sensitivity than the Con at 1 month postoperatively. All the above differences were statistically significant. According to the Cox multivariate regression analysis, treatment modality was the influencing factor for the efficacy of DME patients. CONCLUSIONS IVC + MPL have better clinical efficacy than IVC alone for DME. The combined modality can improve patients' visual quality, inhibit DME, and reduce medication frequency.
Collapse
Affiliation(s)
- Jun Liu
- Department of Ophthalmology, The First People’s Hospital of Yunnan ProvinceKunming 650100, Yunnan, P. R. China,Department of Ophthalmology, Affiliated Hospital of Kunming University of TechnologyKunming 650032, Yunnan, P. R. China
| | - Rui Li
- Dehong Hospital of Traditional Chinese MedicineLuxi 678400, Yunnan, P. R. China
| | - Kunping Han
- Department of Ophthalmology, The First People’s Hospital of Yunnan ProvinceKunming 650100, Yunnan, P. R. China,Department of Ophthalmology, Affiliated Hospital of Kunming University of TechnologyKunming 650032, Yunnan, P. R. China
| | - Xiang Yu
- Kunming Sikang EyeClinicKunming 650032, Yunnan, P. R. China
| | - Yi Tang
- Department of Ophthalmology, The First People’s Hospital of Yunnan ProvinceKunming 650100, Yunnan, P. R. China,Department of Ophthalmology, Affiliated Hospital of Kunming University of TechnologyKunming 650032, Yunnan, P. R. China
| | - Haiyan Zhao
- Department of Ophthalmology, The First People’s Hospital of Yunnan ProvinceKunming 650100, Yunnan, P. R. China,Department of Ophthalmology, Affiliated Hospital of Kunming University of TechnologyKunming 650032, Yunnan, P. R. China
| |
Collapse
|